Glen Eagle Advisors’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-500
| Closed | -$1.26K | – | 1020 |
|
|
2021
Q3 | $1.26K | Hold |
500
| – | – | ﹤0.01% | 975 |
|
|
2021
Q2 | $1.43K | Hold |
500
| – | – | ﹤0.01% | 957 |
|
|
2021
Q1 | $1.18K | Hold |
500
| – | – | ﹤0.01% | 929 |
|
|
2020
Q4 | $880 | Hold |
500
| – | – | ﹤0.01% | 916 |
|
|
2020
Q3 | $468 | Hold |
500
| – | – | ﹤0.01% | 888 |
|
|
2020
Q2 | $435 | Sell |
500
-613
| -55% | -$533 | ﹤0.01% | 860 |
|
|
2020
Q1 | $922 | Sell |
1,113
-750
| -40% | -$621 | ﹤0.01% | 759 |
|
|
2019
Q4 | $1.66K | Hold |
1,863
| – | – | ﹤0.01% | 795 |
|
|
2019
Q3 | $1.83K | Buy |
+1,863
| New | +$1.83K | ﹤0.01% | 714 |
|